nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—testicular cancer—lung cancer	0.411	1	CtDrD
Ifosfamide—CYP2A6—lung cancer	0.171	1	CbGaD
Ifosfamide—CYP3A5—Gefitinib—lung cancer	0.0126	0.0517	CbGbCtD
Ifosfamide—CYP3A5—Teniposide—lung cancer	0.0123	0.0501	CbGbCtD
Ifosfamide—CYP2C19—Gefitinib—lung cancer	0.0102	0.0417	CbGbCtD
Ifosfamide—CYP2C19—Teniposide—lung cancer	0.00989	0.0404	CbGbCtD
Ifosfamide—CYP3A7—Paclitaxel—lung cancer	0.00912	0.0373	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00912	0.0373	CbGbCtD
Ifosfamide—PTGS1—Etoposide—lung cancer	0.00901	0.0368	CbGbCtD
Ifosfamide—CYP3A7—Irinotecan—lung cancer	0.009	0.0368	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.009	0.0368	CbGbCtD
Ifosfamide—CYP2B6—Irinotecan—lung cancer	0.00857	0.035	CbGbCtD
Ifosfamide—CYP2C9—Gefitinib—lung cancer	0.00848	0.0347	CbGbCtD
Ifosfamide—CYP2C9—Teniposide—lung cancer	0.00822	0.0336	CbGbCtD
Ifosfamide—CYP3A5—Crizotinib—lung cancer	0.00775	0.0317	CbGbCtD
Ifosfamide—CYP3A5—Erlotinib—lung cancer	0.00747	0.0306	CbGbCtD
Ifosfamide—CYP2C8—Erlotinib—lung cancer	0.00719	0.0294	CbGbCtD
Ifosfamide—CYP2B6—Cisplatin—lung cancer	0.00698	0.0286	CbGbCtD
Ifosfamide—CYP3A5—Paclitaxel—lung cancer	0.00684	0.028	CbGbCtD
Ifosfamide—CYP3A5—Irinotecan—lung cancer	0.00675	0.0276	CbGbCtD
Ifosfamide—CYP3A7—Docetaxel—lung cancer	0.00659	0.027	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00659	0.027	CbGbCtD
Ifosfamide—CYP2C8—Paclitaxel—lung cancer	0.00658	0.0269	CbGbCtD
Ifosfamide—CYP3A5—Etoposide—lung cancer	0.00541	0.0221	CbGbCtD
Ifosfamide—CYP3A4—Topotecan—lung cancer	0.00539	0.022	CbGbCtD
Ifosfamide—CYP2C8—Etoposide—lung cancer	0.0052	0.0213	CbGbCtD
Ifosfamide—CYP3A5—Docetaxel—lung cancer	0.00495	0.0202	CbGbCtD
Ifosfamide—CYP3A4—Gefitinib—lung cancer	0.00493	0.0202	CbGbCtD
Ifosfamide—CYP3A4—Teniposide—lung cancer	0.00478	0.0195	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—lung cancer	0.00468	0.0191	CbGbCtD
Ifosfamide—CYP2C9—Paclitaxel—lung cancer	0.00459	0.0188	CbGbCtD
Ifosfamide—CYP3A4—Vinorelbine—lung cancer	0.0038	0.0155	CbGbCtD
Ifosfamide—CYP2C9—Cisplatin—lung cancer	0.00369	0.0151	CbGbCtD
Ifosfamide—CYP3A4—Crizotinib—lung cancer	0.00302	0.0124	CbGbCtD
Ifosfamide—CYP3A4—Erlotinib—lung cancer	0.00291	0.0119	CbGbCtD
Ifosfamide—CYP3A4—Paclitaxel—lung cancer	0.00267	0.0109	CbGbCtD
Ifosfamide—CYP3A4—Irinotecan—lung cancer	0.00263	0.0108	CbGbCtD
Ifosfamide—CYP3A4—Vinblastine—lung cancer	0.00234	0.00957	CbGbCtD
Ifosfamide—CYP3A4—Etoposide—lung cancer	0.00211	0.00862	CbGbCtD
Ifosfamide—CYP3A4—Docetaxel—lung cancer	0.00193	0.00789	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—lung cancer	0.00144	0.00588	CbGbCtD
Ifosfamide—Cyclophosphamide—CYP2A6—lung cancer	0.00103	0.729	CrCbGaD
Ifosfamide—Cyclophosphamide—ABCB1—lung cancer	0.000382	0.271	CrCbGaD
Ifosfamide—Convulsion—Docetaxel—lung cancer	2.15e-05	0.000173	CcSEcCtD
Ifosfamide—Paraesthesia—Paclitaxel—lung cancer	2.14e-05	0.000172	CcSEcCtD
Ifosfamide—Hypertension—Docetaxel—lung cancer	2.14e-05	0.000172	CcSEcCtD
Ifosfamide—Agranulocytosis—Methotrexate—lung cancer	2.13e-05	0.000172	CcSEcCtD
Ifosfamide—Dyspnoea—Paclitaxel—lung cancer	2.13e-05	0.000171	CcSEcCtD
Ifosfamide—Somnolence—Paclitaxel—lung cancer	2.12e-05	0.000171	CcSEcCtD
Ifosfamide—Decreased appetite—Etoposide—lung cancer	2.11e-05	0.00017	CcSEcCtD
Ifosfamide—Myalgia—Docetaxel—lung cancer	2.11e-05	0.00017	CcSEcCtD
Ifosfamide—Chest pain—Docetaxel—lung cancer	2.11e-05	0.00017	CcSEcCtD
Ifosfamide—Arthralgia—Docetaxel—lung cancer	2.11e-05	0.00017	CcSEcCtD
Ifosfamide—Pancytopenia—Doxorubicin—lung cancer	2.11e-05	0.00017	CcSEcCtD
Ifosfamide—Nausea—Vinorelbine—lung cancer	2.11e-05	0.00017	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Etoposide—lung cancer	2.1e-05	0.000169	CcSEcCtD
Ifosfamide—Body temperature increased—Cisplatin—lung cancer	2.1e-05	0.000169	CcSEcCtD
Ifosfamide—Asthenia—Irinotecan—lung cancer	2.1e-05	0.000169	CcSEcCtD
Ifosfamide—Fatigue—Etoposide—lung cancer	2.1e-05	0.000169	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	2.09e-05	0.000169	CcSEcCtD
Ifosfamide—Pain—Etoposide—lung cancer	2.08e-05	0.000167	CcSEcCtD
Ifosfamide—Constipation—Etoposide—lung cancer	2.08e-05	0.000167	CcSEcCtD
Ifosfamide—Dysuria—Doxorubicin—lung cancer	2.07e-05	0.000167	CcSEcCtD
Ifosfamide—Decreased appetite—Paclitaxel—lung cancer	2.07e-05	0.000167	CcSEcCtD
Ifosfamide—Haemoglobin—Methotrexate—lung cancer	2.06e-05	0.000166	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Paclitaxel—lung cancer	2.06e-05	0.000166	CcSEcCtD
Ifosfamide—Fatigue—Paclitaxel—lung cancer	2.06e-05	0.000166	CcSEcCtD
Ifosfamide—Haemorrhage—Methotrexate—lung cancer	2.05e-05	0.000165	CcSEcCtD
Ifosfamide—Hepatitis—Methotrexate—lung cancer	2.05e-05	0.000165	CcSEcCtD
Ifosfamide—Pollakiuria—Doxorubicin—lung cancer	2.05e-05	0.000165	CcSEcCtD
Ifosfamide—Asthenia—Gemcitabine—lung cancer	2.04e-05	0.000165	CcSEcCtD
Ifosfamide—Pain—Paclitaxel—lung cancer	2.04e-05	0.000164	CcSEcCtD
Ifosfamide—Constipation—Paclitaxel—lung cancer	2.04e-05	0.000164	CcSEcCtD
Ifosfamide—Confusional state—Docetaxel—lung cancer	2.04e-05	0.000164	CcSEcCtD
Ifosfamide—Urinary tract disorder—Methotrexate—lung cancer	2.03e-05	0.000163	CcSEcCtD
Ifosfamide—Oedema—Docetaxel—lung cancer	2.02e-05	0.000163	CcSEcCtD
Ifosfamide—Anaphylactic shock—Docetaxel—lung cancer	2.02e-05	0.000163	CcSEcCtD
Ifosfamide—Pruritus—Gemcitabine—lung cancer	2.02e-05	0.000162	CcSEcCtD
Ifosfamide—Urethral disorder—Methotrexate—lung cancer	2.01e-05	0.000162	CcSEcCtD
Ifosfamide—Infection—Docetaxel—lung cancer	2.01e-05	0.000162	CcSEcCtD
Ifosfamide—Feeling abnormal—Etoposide—lung cancer	2e-05	0.000161	CcSEcCtD
Ifosfamide—Hyperglycaemia—Doxorubicin—lung cancer	2e-05	0.000161	CcSEcCtD
Ifosfamide—Diarrhoea—Irinotecan—lung cancer	2e-05	0.000161	CcSEcCtD
Ifosfamide—Pneumonia—Doxorubicin—lung cancer	1.99e-05	0.00016	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Etoposide—lung cancer	1.99e-05	0.00016	CcSEcCtD
Ifosfamide—Nervous system disorder—Docetaxel—lung cancer	1.98e-05	0.00016	CcSEcCtD
Ifosfamide—Thrombocytopenia—Docetaxel—lung cancer	1.98e-05	0.000159	CcSEcCtD
Ifosfamide—Infestation NOS—Doxorubicin—lung cancer	1.98e-05	0.000159	CcSEcCtD
Ifosfamide—Infestation—Doxorubicin—lung cancer	1.98e-05	0.000159	CcSEcCtD
Ifosfamide—Visual impairment—Methotrexate—lung cancer	1.98e-05	0.000159	CcSEcCtD
Ifosfamide—Feeling abnormal—Paclitaxel—lung cancer	1.97e-05	0.000158	CcSEcCtD
Ifosfamide—Skin disorder—Docetaxel—lung cancer	1.96e-05	0.000158	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Doxorubicin—lung cancer	1.96e-05	0.000158	CcSEcCtD
Ifosfamide—Hypersensitivity—Cisplatin—lung cancer	1.96e-05	0.000157	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Paclitaxel—lung cancer	1.95e-05	0.000157	CcSEcCtD
Ifosfamide—Diarrhoea—Gemcitabine—lung cancer	1.95e-05	0.000157	CcSEcCtD
Ifosfamide—Renal failure—Doxorubicin—lung cancer	1.94e-05	0.000157	CcSEcCtD
Ifosfamide—Erythema multiforme—Methotrexate—lung cancer	1.94e-05	0.000156	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Doxorubicin—lung cancer	1.94e-05	0.000156	CcSEcCtD
Ifosfamide—Dizziness—Irinotecan—lung cancer	1.93e-05	0.000156	CcSEcCtD
Ifosfamide—Urticaria—Etoposide—lung cancer	1.93e-05	0.000156	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—lung cancer	1.93e-05	0.000155	CcSEcCtD
Ifosfamide—Anorexia—Docetaxel—lung cancer	1.93e-05	0.000155	CcSEcCtD
Ifosfamide—Abdominal pain—Etoposide—lung cancer	1.92e-05	0.000155	CcSEcCtD
Ifosfamide—Body temperature increased—Etoposide—lung cancer	1.92e-05	0.000155	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—lung cancer	1.92e-05	0.000155	CcSEcCtD
Ifosfamide—Eye disorder—Methotrexate—lung cancer	1.92e-05	0.000154	CcSEcCtD
Ifosfamide—Tinnitus—Methotrexate—lung cancer	1.91e-05	0.000154	CcSEcCtD
Ifosfamide—Asthenia—Cisplatin—lung cancer	1.91e-05	0.000153	CcSEcCtD
Ifosfamide—Cardiac disorder—Methotrexate—lung cancer	1.9e-05	0.000153	CcSEcCtD
Ifosfamide—Urticaria—Paclitaxel—lung cancer	1.9e-05	0.000153	CcSEcCtD
Ifosfamide—Hypotension—Docetaxel—lung cancer	1.89e-05	0.000152	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—lung cancer	1.89e-05	0.000152	CcSEcCtD
Ifosfamide—Body temperature increased—Paclitaxel—lung cancer	1.89e-05	0.000152	CcSEcCtD
Ifosfamide—Abdominal pain—Paclitaxel—lung cancer	1.89e-05	0.000152	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—lung cancer	1.87e-05	0.000151	CcSEcCtD
Ifosfamide—Angiopathy—Methotrexate—lung cancer	1.86e-05	0.00015	CcSEcCtD
Ifosfamide—Vomiting—Irinotecan—lung cancer	1.86e-05	0.00015	CcSEcCtD
Ifosfamide—Immune system disorder—Methotrexate—lung cancer	1.85e-05	0.000149	CcSEcCtD
Ifosfamide—Mediastinal disorder—Methotrexate—lung cancer	1.85e-05	0.000149	CcSEcCtD
Ifosfamide—Agranulocytosis—Doxorubicin—lung cancer	1.85e-05	0.000149	CcSEcCtD
Ifosfamide—Rash—Irinotecan—lung cancer	1.84e-05	0.000148	CcSEcCtD
Ifosfamide—Dermatitis—Irinotecan—lung cancer	1.84e-05	0.000148	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Docetaxel—lung cancer	1.84e-05	0.000148	CcSEcCtD
Ifosfamide—Chills—Methotrexate—lung cancer	1.84e-05	0.000148	CcSEcCtD
Ifosfamide—Diarrhoea—Cisplatin—lung cancer	1.82e-05	0.000146	CcSEcCtD
Ifosfamide—Paraesthesia—Docetaxel—lung cancer	1.82e-05	0.000146	CcSEcCtD
Ifosfamide—Alopecia—Methotrexate—lung cancer	1.81e-05	0.000146	CcSEcCtD
Ifosfamide—Vomiting—Gemcitabine—lung cancer	1.81e-05	0.000146	CcSEcCtD
Ifosfamide—Bradycardia—Doxorubicin—lung cancer	1.81e-05	0.000146	CcSEcCtD
Ifosfamide—Dyspnoea—Docetaxel—lung cancer	1.8e-05	0.000145	CcSEcCtD
Ifosfamide—Somnolence—Docetaxel—lung cancer	1.8e-05	0.000145	CcSEcCtD
Ifosfamide—Mental disorder—Methotrexate—lung cancer	1.8e-05	0.000145	CcSEcCtD
Ifosfamide—Rash—Gemcitabine—lung cancer	1.8e-05	0.000145	CcSEcCtD
Ifosfamide—Dermatitis—Gemcitabine—lung cancer	1.79e-05	0.000144	CcSEcCtD
Ifosfamide—Hypersensitivity—Etoposide—lung cancer	1.79e-05	0.000144	CcSEcCtD
Ifosfamide—Erythema—Methotrexate—lung cancer	1.79e-05	0.000144	CcSEcCtD
Ifosfamide—Malnutrition—Methotrexate—lung cancer	1.79e-05	0.000144	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—lung cancer	1.79e-05	0.000144	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—lung cancer	1.78e-05	0.000143	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—lung cancer	1.78e-05	0.000143	CcSEcCtD
Ifosfamide—Decreased appetite—Docetaxel—lung cancer	1.76e-05	0.000141	CcSEcCtD
Ifosfamide—Hypersensitivity—Paclitaxel—lung cancer	1.76e-05	0.000141	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—lung cancer	1.75e-05	0.000141	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Docetaxel—lung cancer	1.75e-05	0.00014	CcSEcCtD
Ifosfamide—Asthenia—Etoposide—lung cancer	1.75e-05	0.00014	CcSEcCtD
Ifosfamide—Connective tissue disorder—Doxorubicin—lung cancer	1.75e-05	0.00014	CcSEcCtD
Ifosfamide—Fatigue—Docetaxel—lung cancer	1.74e-05	0.00014	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—lung cancer	1.74e-05	0.00014	CcSEcCtD
Ifosfamide—Nausea—Irinotecan—lung cancer	1.74e-05	0.00014	CcSEcCtD
Ifosfamide—Pain—Docetaxel—lung cancer	1.73e-05	0.000139	CcSEcCtD
Ifosfamide—Constipation—Docetaxel—lung cancer	1.73e-05	0.000139	CcSEcCtD
Ifosfamide—Pruritus—Etoposide—lung cancer	1.72e-05	0.000139	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—lung cancer	1.71e-05	0.000138	CcSEcCtD
Ifosfamide—Asthenia—Paclitaxel—lung cancer	1.71e-05	0.000138	CcSEcCtD
Ifosfamide—Nausea—Gemcitabine—lung cancer	1.69e-05	0.000136	CcSEcCtD
Ifosfamide—Vomiting—Cisplatin—lung cancer	1.69e-05	0.000136	CcSEcCtD
Ifosfamide—Pruritus—Paclitaxel—lung cancer	1.69e-05	0.000136	CcSEcCtD
Ifosfamide—Vision blurred—Methotrexate—lung cancer	1.68e-05	0.000135	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—lung cancer	1.68e-05	0.000135	CcSEcCtD
Ifosfamide—Rash—Cisplatin—lung cancer	1.67e-05	0.000135	CcSEcCtD
Ifosfamide—Dermatitis—Cisplatin—lung cancer	1.67e-05	0.000135	CcSEcCtD
Ifosfamide—Feeling abnormal—Docetaxel—lung cancer	1.67e-05	0.000134	CcSEcCtD
Ifosfamide—Diarrhoea—Etoposide—lung cancer	1.66e-05	0.000134	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—lung cancer	1.66e-05	0.000134	CcSEcCtD
Ifosfamide—Ill-defined disorder—Methotrexate—lung cancer	1.66e-05	0.000133	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—lung cancer	1.66e-05	0.000133	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Docetaxel—lung cancer	1.65e-05	0.000133	CcSEcCtD
Ifosfamide—Anaemia—Methotrexate—lung cancer	1.65e-05	0.000133	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—lung cancer	1.65e-05	0.000133	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—lung cancer	1.65e-05	0.000133	CcSEcCtD
Ifosfamide—Diarrhoea—Paclitaxel—lung cancer	1.63e-05	0.000131	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—lung cancer	1.61e-05	0.00013	CcSEcCtD
Ifosfamide—Malaise—Methotrexate—lung cancer	1.61e-05	0.00013	CcSEcCtD
Ifosfamide—Dizziness—Etoposide—lung cancer	1.61e-05	0.000129	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—lung cancer	1.6e-05	0.000129	CcSEcCtD
Ifosfamide—Vertigo—Methotrexate—lung cancer	1.6e-05	0.000129	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—lung cancer	1.6e-05	0.000129	CcSEcCtD
Ifosfamide—Abdominal pain—Docetaxel—lung cancer	1.6e-05	0.000129	CcSEcCtD
Ifosfamide—Body temperature increased—Docetaxel—lung cancer	1.6e-05	0.000129	CcSEcCtD
Ifosfamide—Leukopenia—Methotrexate—lung cancer	1.6e-05	0.000129	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—lung cancer	1.59e-05	0.000128	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—lung cancer	1.59e-05	0.000128	CcSEcCtD
Ifosfamide—Dizziness—Paclitaxel—lung cancer	1.58e-05	0.000127	CcSEcCtD
Ifosfamide—Nausea—Cisplatin—lung cancer	1.58e-05	0.000127	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—lung cancer	1.57e-05	0.000126	CcSEcCtD
Ifosfamide—Cough—Methotrexate—lung cancer	1.56e-05	0.000125	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—lung cancer	1.56e-05	0.000125	CcSEcCtD
Ifosfamide—Convulsion—Methotrexate—lung cancer	1.55e-05	0.000124	CcSEcCtD
Ifosfamide—Vomiting—Etoposide—lung cancer	1.55e-05	0.000124	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—lung cancer	1.55e-05	0.000124	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—lung cancer	1.55e-05	0.000124	CcSEcCtD
Ifosfamide—Rash—Etoposide—lung cancer	1.53e-05	0.000123	CcSEcCtD
Ifosfamide—Dermatitis—Etoposide—lung cancer	1.53e-05	0.000123	CcSEcCtD
Ifosfamide—Arthralgia—Methotrexate—lung cancer	1.52e-05	0.000122	CcSEcCtD
Ifosfamide—Chest pain—Methotrexate—lung cancer	1.52e-05	0.000122	CcSEcCtD
Ifosfamide—Myalgia—Methotrexate—lung cancer	1.52e-05	0.000122	CcSEcCtD
Ifosfamide—Vomiting—Paclitaxel—lung cancer	1.52e-05	0.000122	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	1.51e-05	0.000121	CcSEcCtD
Ifosfamide—Rash—Paclitaxel—lung cancer	1.5e-05	0.000121	CcSEcCtD
Ifosfamide—Dermatitis—Paclitaxel—lung cancer	1.5e-05	0.000121	CcSEcCtD
Ifosfamide—Discomfort—Methotrexate—lung cancer	1.5e-05	0.000121	CcSEcCtD
Ifosfamide—Hypersensitivity—Docetaxel—lung cancer	1.49e-05	0.00012	CcSEcCtD
Ifosfamide—Confusional state—Methotrexate—lung cancer	1.47e-05	0.000118	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methotrexate—lung cancer	1.46e-05	0.000117	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—lung cancer	1.46e-05	0.000117	CcSEcCtD
Ifosfamide—Asthenia—Docetaxel—lung cancer	1.45e-05	0.000117	CcSEcCtD
Ifosfamide—Infection—Methotrexate—lung cancer	1.45e-05	0.000117	CcSEcCtD
Ifosfamide—Nausea—Etoposide—lung cancer	1.45e-05	0.000116	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—lung cancer	1.43e-05	0.000115	CcSEcCtD
Ifosfamide—Pruritus—Docetaxel—lung cancer	1.43e-05	0.000115	CcSEcCtD
Ifosfamide—Nervous system disorder—Methotrexate—lung cancer	1.43e-05	0.000115	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—lung cancer	1.43e-05	0.000115	CcSEcCtD
Ifosfamide—Thrombocytopenia—Methotrexate—lung cancer	1.43e-05	0.000115	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—lung cancer	1.42e-05	0.000114	CcSEcCtD
Ifosfamide—Nausea—Paclitaxel—lung cancer	1.42e-05	0.000114	CcSEcCtD
Ifosfamide—Skin disorder—Methotrexate—lung cancer	1.42e-05	0.000114	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methotrexate—lung cancer	1.41e-05	0.000113	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—lung cancer	1.39e-05	0.000112	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—lung cancer	1.39e-05	0.000112	CcSEcCtD
Ifosfamide—Anorexia—Methotrexate—lung cancer	1.39e-05	0.000112	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—lung cancer	1.38e-05	0.000111	CcSEcCtD
Ifosfamide—Diarrhoea—Docetaxel—lung cancer	1.38e-05	0.000111	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—lung cancer	1.37e-05	0.00011	CcSEcCtD
Ifosfamide—Hypotension—Methotrexate—lung cancer	1.36e-05	0.00011	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—lung cancer	1.35e-05	0.000109	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—lung cancer	1.34e-05	0.000108	CcSEcCtD
Ifosfamide—Dizziness—Docetaxel—lung cancer	1.34e-05	0.000108	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—lung cancer	1.33e-05	0.000107	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Methotrexate—lung cancer	1.33e-05	0.000107	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—lung cancer	1.32e-05	0.000106	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—lung cancer	1.32e-05	0.000106	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—lung cancer	1.32e-05	0.000106	CcSEcCtD
Ifosfamide—Paraesthesia—Methotrexate—lung cancer	1.31e-05	0.000105	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.31e-05	0.000105	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—lung cancer	1.3e-05	0.000105	CcSEcCtD
Ifosfamide—Dyspnoea—Methotrexate—lung cancer	1.3e-05	0.000105	CcSEcCtD
Ifosfamide—Somnolence—Methotrexate—lung cancer	1.3e-05	0.000104	CcSEcCtD
Ifosfamide—Vomiting—Docetaxel—lung cancer	1.29e-05	0.000103	CcSEcCtD
Ifosfamide—Rash—Docetaxel—lung cancer	1.27e-05	0.000103	CcSEcCtD
Ifosfamide—Dermatitis—Docetaxel—lung cancer	1.27e-05	0.000102	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—lung cancer	1.27e-05	0.000102	CcSEcCtD
Ifosfamide—Decreased appetite—Methotrexate—lung cancer	1.27e-05	0.000102	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—lung cancer	1.26e-05	0.000102	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—lung cancer	1.26e-05	0.000102	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Methotrexate—lung cancer	1.26e-05	0.000101	CcSEcCtD
Ifosfamide—Fatigue—Methotrexate—lung cancer	1.26e-05	0.000101	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—lung cancer	1.25e-05	0.000101	CcSEcCtD
Ifosfamide—Pain—Methotrexate—lung cancer	1.25e-05	0.0001	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—lung cancer	1.24e-05	9.96e-05	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—lung cancer	1.24e-05	9.94e-05	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—lung cancer	1.23e-05	9.86e-05	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—lung cancer	1.22e-05	9.82e-05	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—lung cancer	1.2e-05	9.68e-05	CcSEcCtD
Ifosfamide—Nausea—Docetaxel—lung cancer	1.2e-05	9.66e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Methotrexate—lung cancer	1.2e-05	9.66e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Methotrexate—lung cancer	1.19e-05	9.59e-05	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—lung cancer	1.18e-05	9.49e-05	CcSEcCtD
Ifosfamide—Urticaria—Methotrexate—lung cancer	1.16e-05	9.32e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Methotrexate—lung cancer	1.15e-05	9.27e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Methotrexate—lung cancer	1.15e-05	9.27e-05	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.15e-05	9.25e-05	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—lung cancer	1.13e-05	9.12e-05	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—lung cancer	1.13e-05	9.05e-05	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—lung cancer	1.12e-05	9.03e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Doxorubicin—lung cancer	1.1e-05	8.83e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—lung cancer	1.09e-05	8.77e-05	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—lung cancer	1.09e-05	8.75e-05	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—lung cancer	1.08e-05	8.68e-05	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—lung cancer	1.08e-05	8.68e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Methotrexate—lung cancer	1.07e-05	8.64e-05	CcSEcCtD
Ifosfamide—Asthenia—Methotrexate—lung cancer	1.05e-05	8.41e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—lung cancer	1.04e-05	8.37e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—lung cancer	1.03e-05	8.3e-05	CcSEcCtD
Ifosfamide—Pruritus—Methotrexate—lung cancer	1.03e-05	8.3e-05	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—lung cancer	1e-05	8.07e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—lung cancer	9.98e-06	8.03e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—lung cancer	9.98e-06	8.03e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Methotrexate—lung cancer	9.97e-06	8.02e-05	CcSEcCtD
Ifosfamide—Dizziness—Methotrexate—lung cancer	9.64e-06	7.76e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—lung cancer	9.3e-06	7.48e-05	CcSEcCtD
Ifosfamide—Vomiting—Methotrexate—lung cancer	9.27e-06	7.46e-05	CcSEcCtD
Ifosfamide—Rash—Methotrexate—lung cancer	9.19e-06	7.39e-05	CcSEcCtD
Ifosfamide—Dermatitis—Methotrexate—lung cancer	9.18e-06	7.39e-05	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—lung cancer	9.05e-06	7.29e-05	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—lung cancer	8.93e-06	7.18e-05	CcSEcCtD
Ifosfamide—Nausea—Methotrexate—lung cancer	8.66e-06	6.97e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—lung cancer	8.63e-06	6.95e-05	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—lung cancer	8.34e-06	6.72e-05	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—lung cancer	8.02e-06	6.46e-05	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—lung cancer	7.96e-06	6.4e-05	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—lung cancer	7.95e-06	6.4e-05	CcSEcCtD
Ifosfamide—Nausea—Doxorubicin—lung cancer	7.5e-06	6.03e-05	CcSEcCtD
Ifosfamide—CYP2C9—Metabolism—GNG11—lung cancer	3.97e-06	8.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.96e-06	8.36e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.95e-06	8.35e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—TYMS—lung cancer	3.94e-06	8.32e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ADCY1—lung cancer	3.92e-06	8.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ABCG2—lung cancer	3.92e-06	8.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ENO1—lung cancer	3.91e-06	8.27e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP1A1—lung cancer	3.9e-06	8.25e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.9e-06	8.24e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTM1—lung cancer	3.89e-06	8.23e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ERCC2—lung cancer	3.87e-06	8.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.85e-06	8.13e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ENO2—lung cancer	3.84e-06	8.12e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—HPGDS—lung cancer	3.84e-06	8.12e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PPP2R1B—lung cancer	3.82e-06	8.07e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2A7—lung cancer	3.81e-06	8.06e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALDOA—lung cancer	3.78e-06	7.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.77e-06	7.96e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SDC4—lung cancer	3.73e-06	7.89e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTT1—lung cancer	3.73e-06	7.87e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—STK11—lung cancer	3.69e-06	7.81e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP1A1—lung cancer	3.69e-06	7.8e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GCLC—lung cancer	3.68e-06	7.78e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2A6—lung cancer	3.68e-06	7.78e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NCOA3—lung cancer	3.67e-06	7.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.67e-06	7.75e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ERCC2—lung cancer	3.66e-06	7.73e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CB—lung cancer	3.63e-06	7.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—STK11—lung cancer	3.61e-06	7.63e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.61e-06	7.63e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTGS2—lung cancer	3.6e-06	7.61e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ADCY1—lung cancer	3.57e-06	7.55e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ABCG2—lung cancer	3.57e-06	7.55e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP2E1—lung cancer	3.51e-06	7.41e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ENO2—lung cancer	3.5e-06	7.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—HPGDS—lung cancer	3.5e-06	7.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ENO1—lung cancer	3.49e-06	7.38e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPP2R1B—lung cancer	3.48e-06	7.36e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.48e-06	7.35e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—NQO1—lung cancer	3.47e-06	7.33e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—APOA1—lung cancer	3.45e-06	7.3e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.43e-06	7.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.43e-06	7.26e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTP1—lung cancer	3.42e-06	7.22e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—RRM1—lung cancer	3.4e-06	7.18e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA3—lung cancer	3.4e-06	7.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTT1—lung cancer	3.4e-06	7.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.4e-06	7.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.37e-06	7.11e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP2A6—lung cancer	3.36e-06	7.1e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GCLC—lung cancer	3.36e-06	7.1e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—APOA1—lung cancer	3.35e-06	7.08e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.34e-06	7.07e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTP1—lung cancer	3.34e-06	7.06e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CAT—lung cancer	3.33e-06	7.03e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CAT—lung cancer	3.25e-06	6.87e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ABCB1—lung cancer	3.23e-06	6.84e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.21e-06	6.78e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—B4GALT5—lung cancer	3.19e-06	6.75e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ENO1—lung cancer	3.18e-06	6.73e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—TYMS—lung cancer	3.18e-06	6.72e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.17e-06	6.7e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—APOA1—lung cancer	3.17e-06	6.69e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ABCB1—lung cancer	3.16e-06	6.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CG—lung cancer	3.15e-06	6.66e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—lung cancer	3.14e-06	6.64e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—lung cancer	3.14e-06	6.64e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP2E1—lung cancer	3.13e-06	6.62e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.13e-06	6.62e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—STK11—lung cancer	3.13e-06	6.61e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA4—lung cancer	3.11e-06	6.57e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—TYMS—lung cancer	3.11e-06	6.56e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—NQO1—lung cancer	3.1e-06	6.54e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—lung cancer	3.07e-06	6.49e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CG—lung cancer	3.06e-06	6.46e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.03e-06	6.41e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA2—lung cancer	3.03e-06	6.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3e-06	6.35e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—POMC—lung cancer	3e-06	6.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—EP300—lung cancer	2.99e-06	6.33e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1A1—lung cancer	2.98e-06	6.29e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ERCC2—lung cancer	2.95e-06	6.24e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.93e-06	6.2e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CREBBP—lung cancer	2.92e-06	6.18e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTA1—lung cancer	2.92e-06	6.18e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1A1—lung cancer	2.91e-06	6.15e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—POMC—lung cancer	2.91e-06	6.15e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTP1—lung cancer	2.89e-06	6.12e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CG—lung cancer	2.89e-06	6.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCC3—lung cancer	2.89e-06	6.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ERCC2—lung cancer	2.89e-06	6.1e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP2E1—lung cancer	2.85e-06	6.03e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CREBBP—lung cancer	2.83e-06	5.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—NQO1—lung cancer	2.82e-06	5.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CAT—lung cancer	2.82e-06	5.95e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.8e-06	5.92e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKR1C1—lung cancer	2.8e-06	5.91e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—STK11—lung cancer	2.79e-06	5.9e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CD—lung cancer	2.77e-06	5.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.76e-06	5.84e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—POMC—lung cancer	2.75e-06	5.81e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.74e-06	5.79e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ABCB1—lung cancer	2.74e-06	5.79e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ALB—lung cancer	2.74e-06	5.78e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—UGT1A1—lung cancer	2.72e-06	5.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—TYMS—lung cancer	2.69e-06	5.69e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CD—lung cancer	2.69e-06	5.68e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CREBBP—lung cancer	2.68e-06	5.66e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—lung cancer	2.66e-06	5.62e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ALB—lung cancer	2.65e-06	5.61e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.62e-06	5.54e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GNG11—lung cancer	2.62e-06	5.54e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTP1—lung cancer	2.58e-06	5.46e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—APOA1—lung cancer	2.55e-06	5.4e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—STK11—lung cancer	2.54e-06	5.38e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CD—lung cancer	2.54e-06	5.37e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1A1—lung cancer	2.52e-06	5.33e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CAT—lung cancer	2.51e-06	5.31e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ALB—lung cancer	2.51e-06	5.3e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ERCC2—lung cancer	2.5e-06	5.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.5e-06	5.28e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—APOA1—lung cancer	2.5e-06	5.28e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALDOA—lung cancer	2.49e-06	5.27e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ABCB1—lung cancer	2.44e-06	5.17e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NCOA3—lung cancer	2.42e-06	5.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CB—lung cancer	2.42e-06	5.11e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—TYMS—lung cancer	2.4e-06	5.07e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—lung cancer	2.39e-06	5.06e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.39e-06	5.05e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—lung cancer	2.37e-06	5.02e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ADCY1—lung cancer	2.36e-06	4.98e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCG2—lung cancer	2.36e-06	4.98e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTP1—lung cancer	2.35e-06	4.98e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CB—lung cancer	2.34e-06	4.95e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CG—lung cancer	2.33e-06	4.93e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—lung cancer	2.32e-06	4.9e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—HPGDS—lung cancer	2.31e-06	4.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ENO2—lung cancer	2.31e-06	4.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.3e-06	4.85e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CAT—lung cancer	2.29e-06	4.84e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CG—lung cancer	2.28e-06	4.82e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.28e-06	4.82e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1A1—lung cancer	2.25e-06	4.76e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTT1—lung cancer	2.24e-06	4.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ERCC2—lung cancer	2.23e-06	4.72e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ABCB1—lung cancer	2.23e-06	4.71e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—POMC—lung cancer	2.22e-06	4.69e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—lung cancer	2.22e-06	4.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GCLC—lung cancer	2.21e-06	4.68e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2A6—lung cancer	2.21e-06	4.68e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CB—lung cancer	2.21e-06	4.68e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—lung cancer	2.19e-06	4.64e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—TYMS—lung cancer	2.19e-06	4.63e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—POMC—lung cancer	2.17e-06	4.59e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—lung cancer	2.16e-06	4.57e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—APOA1—lung cancer	2.16e-06	4.57e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CREBBP—lung cancer	2.16e-06	4.57e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CREBBP—lung cancer	2.11e-06	4.47e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ENO1—lung cancer	2.1e-06	4.44e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—lung cancer	2.09e-06	4.41e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.07e-06	4.38e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1A1—lung cancer	2.05e-06	4.34e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CD—lung cancer	2.05e-06	4.33e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ERCC2—lung cancer	2.03e-06	4.3e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ALB—lung cancer	2.02e-06	4.28e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—lung cancer	2.02e-06	4.28e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CD—lung cancer	2e-06	4.24e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—EP300—lung cancer	1.99e-06	4.21e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ALB—lung cancer	1.98e-06	4.18e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CG—lung cancer	1.97e-06	4.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APOA1—lung cancer	1.93e-06	4.08e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—EP300—lung cancer	1.93e-06	4.08e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—lung cancer	1.91e-06	4.04e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP2E1—lung cancer	1.88e-06	3.98e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—POMC—lung cancer	1.88e-06	3.97e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—NQO1—lung cancer	1.86e-06	3.94e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.85e-06	3.91e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CREBBP—lung cancer	1.83e-06	3.87e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—EP300—lung cancer	1.82e-06	3.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—AKT1—lung cancer	1.81e-06	3.83e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CB—lung cancer	1.79e-06	3.78e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—lung cancer	1.77e-06	3.74e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CG—lung cancer	1.76e-06	3.72e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APOA1—lung cancer	1.76e-06	3.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CB—lung cancer	1.75e-06	3.69e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CD—lung cancer	1.74e-06	3.67e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—lung cancer	1.73e-06	3.66e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALB—lung cancer	1.71e-06	3.62e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.69e-06	3.56e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—STK11—lung cancer	1.68e-06	3.55e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—POMC—lung cancer	1.68e-06	3.55e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CREBBP—lung cancer	1.63e-06	3.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CG—lung cancer	1.61e-06	3.4e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTP1—lung cancer	1.55e-06	3.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CD—lung cancer	1.55e-06	3.27e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—lung cancer	1.54e-06	3.26e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—POMC—lung cancer	1.53e-06	3.23e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALB—lung cancer	1.53e-06	3.23e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CB—lung cancer	1.51e-06	3.2e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CAT—lung cancer	1.51e-06	3.19e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—lung cancer	1.51e-06	3.19e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—lung cancer	1.5e-06	3.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CREBBP—lung cancer	1.49e-06	3.15e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—lung cancer	1.47e-06	3.11e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—EP300—lung cancer	1.47e-06	3.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCB1—lung cancer	1.47e-06	3.11e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—TYMS—lung cancer	1.44e-06	3.05e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—EP300—lung cancer	1.44e-06	3.04e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—lung cancer	1.43e-06	3.02e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—lung cancer	1.43e-06	3.02e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CD—lung cancer	1.41e-06	2.99e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALB—lung cancer	1.39e-06	2.95e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1A1—lung cancer	1.35e-06	2.86e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CB—lung cancer	1.35e-06	2.85e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—lung cancer	1.35e-06	2.85e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ERCC2—lung cancer	1.34e-06	2.84e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—lung cancer	1.34e-06	2.83e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—lung cancer	1.31e-06	2.76e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—EP300—lung cancer	1.25e-06	2.63e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CB—lung cancer	1.23e-06	2.6e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—lung cancer	1.22e-06	2.58e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—AKT1—lung cancer	1.2e-06	2.54e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—lung cancer	1.17e-06	2.47e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—AKT1—lung cancer	1.17e-06	2.47e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APOA1—lung cancer	1.16e-06	2.45e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—EP300—lung cancer	1.11e-06	2.35e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—AKT1—lung cancer	1.1e-06	2.33e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—lung cancer	1.09e-06	2.3e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—lung cancer	1.06e-06	2.25e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—lung cancer	1.06e-06	2.25e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CG—lung cancer	1.06e-06	2.24e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—EP300—lung cancer	1.01e-06	2.14e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—POMC—lung cancer	1.01e-06	2.13e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CREBBP—lung cancer	9.82e-07	2.08e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CD—lung cancer	9.31e-07	1.97e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—lung cancer	9.22e-07	1.95e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALB—lung cancer	9.19e-07	1.94e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—AKT1—lung cancer	8.9e-07	1.88e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—AKT1—lung cancer	8.7e-07	1.84e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—lung cancer	8.23e-07	1.74e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CB—lung cancer	8.12e-07	1.72e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—lung cancer	8.04e-07	1.7e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—AKT1—lung cancer	7.53e-07	1.59e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—lung cancer	7.5e-07	1.59e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—lung cancer	7.02e-07	1.48e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—AKT1—lung cancer	6.72e-07	1.42e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—EP300—lung cancer	6.69e-07	1.41e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—AKT1—lung cancer	6.13e-07	1.3e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—lung cancer	4.95e-07	1.05e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—AKT1—lung cancer	4.04e-07	8.55e-06	CbGpPWpGaD
